CALF_News_December_2021_January_2022

8 CALF News • December 2021 | January 2022 • www.calfnews.net States sell their beef in a farm-to-fork production system. And once a person tastesWagyu beef, the differences between it and the beef they buy at the grocery store or even enjoy in a white tablecloth restaurant is obvious. Expanding the grading system in the United States will help consumers andWagyu beef produc- ers alike better define the product. In Japan, Wagyu carcasses are graded A1 to A5, with the top A5 grade show- ing an exceptional amount of marbling. As Japanese taste preferences change, the A5 grade is becoming less and less in demand, Katoh says. But using the Japa- nese grading system as a benchmark, the goal is to develop grades above the top limit of Prime that accurately indicate the amount of marbling and thus the dining experience that consumers can expect fromWagyu beef. Japanese grading shows amount of marbling, but doesn’t indicate taste nor fragrance of the meat, Katoh says.“Brush Creek Ranch has been using Japanese grading as a benchmark, and they are going up to the next level. They are focus- ing on taste and fragrance of their beef, including intramuscular fat,” Katoh says. “In the next few years, when guests eat Brush Creek RanchWagyu beef, they will be able to taste and understand the legacy, heritage and philosophy of the ranch. “We have enough knowledge and skills based on science to create the taste and fragrance in meat that we want. The challenge is to find out what taste and fragrance beef producers want to create. This idea is one of the most important challenges for our industry and Brush Creek Ranch will be a leader.” Back at the Ranch The ranch uses cutting-edge repro- ductive technology but respects the traditions of the western cattle business. “We still do everything on horseback,” Hawkins says.“We try to move themwith as little impact on the ground as we can, and horseback is the best way to do that.” Hawkins and his crew stress the importance of low-stress handling. That’s because it’s a ranch-to-restaurant production system. “Keeping them from birth to slaughter at a very low-stress level is very important,” he says. However, the cows aren’t coddled; calv- ing season starts in April for the first-calf heifers and May for the cows, and the cows calve in the sagebrush. Cowboys ride the cows daily; newborn calves get tagged and receive a prebiotic drench. When branding time rolls around, the calves get a seven-way vaccine and a squirt of Nasalgen. In addition, the calves are dehorned and bull calves are knife cut. “Then, typically, three weeks or a month before weaning, we’ll give them a Vira Shield 6 and another seven-way and an oral wormer,” says Jake Keller, who handles the day-to-day cattle management. CONNECTING THE DOTS Continued from page 6 Continued on page 13  ANADA 200-591, Approved by FDA For intramuscular and subcutaneous use in beef and non-lactating dairy cattle only. BRIEF SUMMARY (For full Prescribing Information, see package insert.) INDICATIONS: Norfenicol is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, and for the treatment of foot rot . Also, it is indicated for control of respiratory disease in cattle at high risk of developing BRD associated with M.haemolytica, P. multocida, and H. somni. CONTRAINDICATIONS: Do not use in animals that have shown hypersensitivity to florfenicol. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. Can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothing. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult physician if irritation persists. Accidental injection of this product may cause local irritation. Consult physician immediately. The risk information provided here is not comprehensive. To learn more, talk about Norfenicol with your veterinarian. For customer service, adverse effects reporting, or to obtain a copy of the MSDS or FDA-approved package insert, call 1-866-591-5777. PRECAUTIONS: Not for use in animals intended for breeding. Effects on bovine reproductive performance, pregnancy, and lactation have not been determined. Intramuscular injection may result in local tissue reaction which persists beyond 28 days. This may result in trim loss at slaughter. Tissue reaction at injection sites other than the neck is likely to be more severe. RESIDUE WARNINGS: Animals intended for human consumption must not be slaughtered within 28 days of the last intramuscular treatment. Animals intended for human consumption must not be slaughtered within 33 days of subcutaneous treatment. Not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows as such use may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. ADVERSE REACTIONS: Inappetence, decreased water consumption, or diarrhea may occur transiently. Manufactured by: Norbrook Laboratories Limited, Newry, BT35 6PU, Co. Down, Northern Ireland. The Norbrook logos and Norfenicol ® are registered trademarks of Norbrook Laboratories Limited.